A novel model of rheumatoid arthritis-associated interstitial lung disease in SKG mice

Experimental Lung Research

Volumn 38, Issue 2, 2012, Pages 55-66

  Keith, Rebecca C ^a   Powers, Jennifer L ^b   Redente, Elizabeth F ^b   Sergew, Amen ^b   Martin, Richard J ^a   Gizinski, Alison ^a   Holers, V Michael ^a   Sakaguchi, Shimon ^c   Riches, David W H ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Bleomycin; Fibrosis; Interstitial pneumonia; Lung injury; Smoking; Zymosan

Indexed keywords

BLEOMYCIN; CIGARETTE SMOKE; COLLAGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE MODEL; EXPOSURE; FLOW CYTOMETRY; HISTOLOGY; IMMUNOLOGICAL TOLERANCE; INFLAMMATORY CELL; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG LAVAGE; MACROPHAGE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ACUTE LUNG INJURY; ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; COLLAGEN; DISEASE MODELS, ANIMAL; FEMALE; LUNG; LUNG COMPLIANCE; LUNG DISEASES, INTERSTITIAL; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS; PULMONARY FIBROSIS; SMOKE;

EID: 84863400140     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902148.2011.636139     Document Type: Article

References (46)

1. Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE: Is the incidence of rheumatoid arthritis rising? Re sults from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum. 2010;62:1576-1582.
2. Olson AL, Swigris JJ, Sprunger DB, Fischer A, Fernandez-Perez ER, Solomon J, Murphy J, Cohen M, Raghu G, Brown KK: Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med. 2011;183:372-378.
3. Cortet B, Perez T, Roux N, Flipo RM, Duquesnoy B, Del-cambre B, Remy-Jardin M: Pulmonary function tests and high resolution computed tomography of the lungs in patients with rheumatoid arthritis. Ann Rheum Dis. 1997;56:596-600. (Pubitemid 27444643)
4. Habib HM, Eisa AA, Arafat WR, Marie MA: Pulmonary involvement in early rheumatoid arthritis patients. Clin Rheuma-tol. 2010;30:217-221.
5. Tanaka N, Kim JS, Newell JD, Brown KK, Cool CD, Meehan R, Emoto T, Matsumoto T, Lynch DA: Rheumatoid arthritis-related lung diseases: CT fndings. Radiology. 2004;232: 81-91. (Pubitemid 38796446)
6. Koduri G, Norton S, Young A, Cox N, Davies P, Devlin J, Dixey J, Gough A, Prouse P, Winfeld J, Williams P: Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology (Oxford). 2010;49:1483-1489.
7. Brown KK: Rheumatoid lung disease. Proc Am Thorac Soc. 2007;4:443-448. (Pubitemid 47435369)
8. Park JH, Kim DS, Park IN, Jang SJ, Kitaichi M, Nicholson AG, Colby TV: Prognosis of fbrotic interstitial pneumonia: id-iopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med. 2007;175:705-711. (Pubitemid 46536486)
9. Hubbard R, Venn A: The impact of coexisting connective tissue disease on survival in patients with fbrosing alveolitis. Rheumatology (Oxford). 2002;41:676-679. (Pubitemid 34618887)
10. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, Saigo K, Morinobu A, Koshiba M, Kuntz KM, Ka-mae I, Kumagai S: Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2007;146:797-808. (Pubitemid 351650500)
11. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ: Antibodies against cyclic citrullinated peptide and IgA rheumatoid fac tor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48:2741-2749. (Pubitemid 37280601)
12. Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L: A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum. 2004;50:3085-3092. (Pubitemid 39371983)
13. Linn-Rasker SP, van der Helm-van Mil AH, van Gaalen FA, Kloppenburg M, de Vries RR, le Cessie S, Breedveld FC, Toes RE, Huizinga TW: Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis. 2006;65:366-371. (Pubitemid 43268227)
14. Lundstrom E, Kallberg H, Alfredsson L, Klareskog L, Padyukov L: Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: all alleles are important. Arthritis Rheum. 2009;60:1597-603.
15. Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J, Ronnelid J, Harris HE, Ulfgren AK, Rantapaa-Dahlqvist S, Eklund A, Padyukov L, Alfredsson L: A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modifed by citrullination. Arthritis Rheum. 2006;54:38-46. (Pubitemid 43122184)
16. Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM: Connective tissue disease-associated interstitial lung disease: a call for clarifcation. Chest. 2010;138:251-256.
17. Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Ya-mazaki S, Sakihama T, Matsutani T, Negishi I, Nakatsuru S, Sakaguchi S: Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature. 2003;426:454-460. (Pubitemid 37490133)
18. Yoshitomi H, Sakaguchi N, Kobayashi K, Brown GD, Tagami T, Sakihama T, Hirota K, Tanaka S, Nomura T, Miki I, Gordon S, Akira S, Nakamura T, Sakaguchi S: A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J Exp Med. 2005;201:949-960. (Pubitemid 40524464)
19. Gould NS, Min E, Gauthier S, Chu HW, Martin R, Day BJ: Aging adversely affects the cigarette smoke-induced glutathione adaptive response in the lung. Am J Respir Crit Care Med. 2010;182:1114-1122.
20. Liu T, Jin H, Ullenbruch M, Hu B, Hashimoto N, Moore B, McKenzie A, Lukacs NW, Phan SH: Regulation of found in in-fammatory zone 1 expression in bleomycin-induced lung fbro-sis: role of IL-4/IL-13 and mediation via STAT-6. J Immunol. 2004;173:3425-3431. (Pubitemid 39142053)
21. Kelly MM, McNagny K, Williams DL, van Rooijen N, Maxwell L, Gwozd C, Mody CH, Kubes P: The lung responds to zymosan in a unique manner independent of toll-like receptors, complement, and dectin-1. Am J Respir Cell Mol Biol. 2008;38:227-238. (Pubitemid 351162845)
22. Lovgren AK, Jania LA, Hartney JM, Parsons KK, Audoly LP, Fitzgerald GA, Tilley SL, Koller BH: COX-2-derived prostacy-clin protects against bleomycin-induced pulmonary fbrosis. Am J Physiol Lung Cell Mol Physiol. 2006;291:L144-L156. (Pubitemid 44148098)
23. Redente EF, Dwyer-Nield LD, Merrick DT, Raina K, Agar-wal R, Pao W, Rice PL, Shroyer KR, Malkinson AM: Tumor progression stage and anatomical site regulate tumor-associated macrophage and bone marrow-derived monocyte polarization. Am J Pathol. 2010;176:2972-29s85.
24. Foster B, Calman P, Fei L, Whitmire J, Whitton J: Detection of Intracellular Cytokines by Flow Cytometry. Current Protocols in Immunology. New York: John Wiley & Sons; 2007:6.24.1-6.24.21.
25. Gundersen HJ, Jensen EB, Kieu K, Nielsen J: The effciency of systematic sampling in stereology-reconsidered. J Microsc. 1999;193(Pt 3):199-211.
26. Hsia CC, Hyde DM, Ochs M, Weibel ER: An offcial research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure. Am J Respir Crit Care Med. 2010;181:394-418.
27. Richter A, Yeager ME, Zaiman A, Cool CD, Voelkel NF, Tuder RM: Impaired transforming growth factor-beta signaling in id-iopathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 2004;170:1340-1348. (Pubitemid 39657199)
28. Frankel SK, Moats-Staats BM, Cool CD, Wynes MW, Stiles AD, Riches DW: Human insulin-like growth factor-IA expression in transgenic mice promotes adenomatous hyperplasia but not pulmonary fbrosis. Am J Physiol Lung Cell Mol Physiol. 2005;288:L805-L812. (Pubitemid 40547905)
29. Team. RDC. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2011. Available at: http://www.R-project.org. Accessed 6th December 2011.
30. Good P: Permutation, Parametric, and Bootstrap Tests of Hypotheses. 3rd ed. New York: Springer; 2005.
31. Benjamini Y and Yekutieli D: The control of the false discovery rate in multiple testing under dependency. Ann Stat. 2001;29:1165-1188. (Pubitemid 33575263)
32. Redente EF, Jacobsen KM, Solomon JJ, Lara AR, Faubel S, Keith RC, Henson PM, Downey GP, Riches DW: Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fbrosis. Am J Physiol Lung Cell Mol Physiol. 2011;301:L510-L518.
33. Rosendahl A, Checchin D, Fehniger TE, ten Dijke P, Heldin CH, Sideras P: Activation of the TGF-beta/activin-Smad2 pathway during allergic airway infammation. Am J Respir Cell Mol Biol. 2001;25:60-68. (Pubitemid 32682706)
34. Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L, Alfredsson L: Quantifcation of the infuence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis. 2003;62:835-841. (Pubitemid 37026493)
35. Makrygiannakis D, Hermansson M, Ulfgren AK, Nicholas AP, Zendman AJ, Eklund A, Grunewald J, Skold CM, Klareskog L, Catrina AI: Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis. 2008;67:1488-1492.
36. Ramos-Casals M, Brito-Zeron P, Munoz S, Soria N, Galiana D, Bertolaccini L, Cuadrado MJ, Khamashta MA: Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore). 2007;86:242-251. (Pubitemid 47067483)
37. Tafti SF, Mokri B, Mohammadi F, Bakhshayesh-Karam M, Emami H, Masjedi MR: Comparison of clinicoradiologic manifestation of nonspecifc interstitial pneumonia and usual interstitial pneumonia/idiopathic pulmonary fbrosis: a report from NRITLD. Ann Thorac Med. 2008;3:140-145.
38. Katzenstein AL, Myers JL: Nonspecifc interstitial pneumonia and the other idiopathic interstitial pneumonias: classifcation and diagnostic criteria. Am J Surg Pathol. 2000;24:1-3. (Pubitemid 30033391)
39. Nagasawa Y, Takada T, Shimizu T, Narita J, Moriyama H, Terada M, Suzuki E, Gejyo F: Infammatory cells in lung disease associated with rheumatoid arthritis. Intern Med. 2009;48:1209-1217.
40. Kolarz G, Scherak O, Popp W, Ritschka L, Thumb N, Wottawa A, Zwick H: Bronchoalveolar lavage in rheumatoid arthritis. Br J Rheumatol. 1993;32:556-561. (Pubitemid 23224930)
41. Keogh KA, Limper AH: Characterization of lymphocyte populations in nonspecifc interstitial pneumonia. Respir Res. 2005;6:137-144.
42. Szlubowski A, Soja J, Grzanka P, Tomaszewska R, Papla B, Kuzdzal J, Cmiel A, Sladek K: TGF-beta1 in bronchoalveo-lar lavage fuid in diffuse parenchymal lung diseases and high-resolution computed tomography score. Pol Arch Med Wewn. 2010;120:270-275.
43. von Asmuth EJ, Maessen JG, van der Linden CJ, Buurman WA: Tumour necrosis factor alpha (TNF-alpha) and inter-leukin 6 in a zymosan-induced shock model. Scand J Immunol. 1990;32:313-319. (Pubitemid 20332708)
44. O'Dea KP, Wilson MR, Dokpesi JO, Wakabayashi K, Tatton L, van Rooijen N, Takata M: Mobilization and margination of bone marrow Gr-1high monocytes during subclinical endo-toxemia predisposes the lungs toward acute injury. J Immunol. 2009;182:1155-1166.
45. Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ: PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays. 2003;25:1106-1118. (Pubitemid 37411770)
46. Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, Holers VM: Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest. 2006;116:961-973.